Study guide

9.5 Regulatory Framework, Proficiency Testing & Competency Assessment

ASCP Hematology Technologist Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Hematopoiesis & Cellular Physiology

1.1 Hematopoiesis, Bone Marrow Microenvironment & Growth Factors 1.2 Erythrocyte Physiology, Metabolism & Destruction Pathways 1.3 Leukocyte Kinetics, Morphology & Phagocytic Function 1.4 Platelet Physiology, Ultrastructure & Thrombopoiesis

2 Chapter 2: Erythrocyte Disorders & Non-Hemolytic Anemias

2.1 Iron Metabolism & Iron Deficiency Anemia 2.2 Anemia of Chronic Inflammation, Sideroblastic Anemias & Lead Toxicity 2.3 Hemoglobinopathies & Qualitative Globin Chain Defects 2.4 Alpha and Beta Thalassemias 2.5 Megaloblastic, Macrocytic & Hypoproliferative Anemias

3 Chapter 3: Hemolytic Anemias & Erythrocytosis

3.1 Intrinsic Hemolytic Anemias: Membrane & Metabolic Defects 3.2 Immune-Mediated Hemolytic Anemias & Paroxysmal Nocturnal Hemoglobinuria 3.3 Non-Immune Extrinsic Hemolytic Anemias & Microangiopathies 3.4 Polycythemia & Erythrocytosis Classification

4 Chapter 4: Benign Leukocyte Alterations, Acute Leukemias & Bone Marrow Evaluation

4.1 Quantitative Leukocyte Alterations, Toxic Change & Leukemoid Reaction 4.2 Inherited Leukocyte Anomalies, Reactive Lymphocytosis & Storage Disorders 4.3 Acute Myeloid Leukemia (AML) & Related Neoplasms 4.4 Acute Lymphoblastic Leukemia (ALL) & Precursor Lymphoid Neoplasms 4.5 Bone Marrow Examination, Differential & M:E Ratio Assessment

5 Chapter 5: Chronic Myeloid Neoplasms, MDS & Mature Lymphoid Neoplasms

5.1 Myelodysplastic Syndromes (MDS) & Overlap Syndromes 5.2 Chronic Myeloproliferative Neoplasms (CML, PV, ET, PMF) 5.3 Chronic Lymphocytic Leukemia & Indolent B-Cell Lymphomas 5.4 Aggressive Lymphomas, Hodgkin Lymphoma & Mature T-Cell Disorders 5.5 Plasma Cell Neoplasms & Monoclonal Gammopathies

6 Chapter 6: Hemostasis: Primary, Secondary & Fibrinolytic Systems

6.1 Primary Hemostasis, Platelet Receptors & Qualitative Platelet Disorders 6.2 Quantitative Platelet Disorders & Immune Thrombocytopenias 6.3 The Coagulation Cascade & Cell-Based Hemostatic Model 6.4 Fibrinolytic System, Natural Anticoagulants & Thrombophilia

7 Chapter 7: Factor Deficiencies, Coagulation Testing & Anticoagulation

7.1 Hereditary Coagulation Factor Deficiencies & von Willebrand Disease 7.2 Acquired Coagulation Factor Deficiencies, Circulating Inhibitors & DIC 7.3 Routine and Specialized Coagulation Testing & Mixing Study Interpretation 7.4 Anticoagulant Therapies, Laboratory Monitoring & Reversal Strategies 7.5 Viscoelastic Testing, Heparin Neutralization & Chromogenic Assays

8 Chapter 8: Hematology Laboratory Testing & Advanced Diagnostics

8.1 Automated Hematology Analyzers, Interference Flags & Manual Methods 8.2 Cytochemical Staining, Flow Cytometry & Molecular Diagnostics 8.3 Erythrocyte Sedimentation Rate, Hemolytic Indicators & Special Erythrocyte Studies 8.4 Cerebrospinal Fluid Analysis, Cell Counts & Cytology 8.5 Serous Effusions & Synovial Fluid Analysis

9 Chapter 9: Laboratory Operations, Quality Assessment & Safety

9.1 The Total Testing Process: Preanalytical, Analytical & Postanalytical Quality 9.2 Quality Control Statistics, Levey-Jennings Charts & Westgard Multirules 9.3 Laboratory Mathematics: Dilutions, Concentration, Molarity & Standard Curves 9.4 Method Evaluation, Diagnostic Statistics & Point-of-Care Testing 9.5 Regulatory Framework, Proficiency Testing & Competency Assessment 9.6 Laboratory Safety: Bloodborne Pathogens, Personal Protective Equipment & Chemical Hygiene 9.7 Emergency Response, Spill Management & Specimen Packaging and Transport 9.8 Hematology Instrumentation: Microscopy, Counters, Analyzers & Centrifuges

9.5 Regulatory Framework, Proficiency Testing & Competency Assessment

Key Takeaways Explain This Topic AI

CLIA '88 is administered by CMS and categorizes testing as waived, provider-performed microscopy, moderate complexity, or high complexity; manual differentials, manual body fluid counts, cytochemical stains, flow cytometry, and bone marrow evaluation are HIGH complexity.

CAP, The Joint Commission, COLA, and AABB hold CMS deemed status, so their accreditation substitutes for a CMS survey; CLSI documents are consensus guidelines, not regulations.

Proficiency testing requires three events per year with routine handling by routine personnel; the passing score is 80 percent per analyte per event, but ABO, Rh, and compatibility testing require 100 percent.

Referring a proficiency testing sample to another laboratory or discussing results before the deadline are the most serious violations and can cost the CLIA certificate; records are retained for two years.

Competency assessment is performed at six months and twelve months in the first year and annually thereafter, documenting all six required elements for each test system.

Last updated: August 2026

Regulatory Framework, Proficiency Testing & Competency Assessment

The Laboratory Operations content area explicitly names regulation, including proficiency testing, competency assessment, and accreditation standards , and the guideline states that regulatory questions on the examination are based on United States sources . Learn the rules as rules, with their numeric thresholds.

1. CLIA '88: The Governing Statute

The Clinical Laboratory Improvement Amendments of 1988 place every United States facility that tests human specimens for health assessment under a single framework administered by the Centers for Medicare and Medicaid Services, with scientific support from the Centers for Disease Control and Prevention and device categorization by the Food and Drug Administration.

Test Complexity Categories

Category Description Hematology Examples

Waived Simple, FDA-cleared for home use, negligible risk of erroneous result Capillary hemoglobin by handheld meter, point-of-care INR meter, spun microhematocrit in some settings

Provider-Performed Microscopy Microscopy performed by a physician, midlevel provider, or dentist on a specimen that is unstable Wet mounts, fern test (not a hematology bench activity)

Moderate complexity Most automated systems with limited operator judgment Automated CBC with automated differential

High complexity Substantial operator interpretation and judgment Manual peripheral blood differentials, manual body fluid counts, cytochemical staining, flow cytometry immunophenotyping, bone marrow evaluation, coagulation factor assays

The complexity category determines personnel qualifications, quality control obligations, proficiency testing enrollment, and inspection frequency. CLIA certificates correspond to this structure: Certificate of Waiver, Certificate for Provider-Performed Microscopy, Certificate of Registration, Certificate of Compliance (inspected by CMS), and Certificate of Accreditation (inspected by an approved accreditor).

Accrediting Organizations with Deemed Status

The College of American Pathologists (CAP) , The Joint Commission , COLA , and AABB hold CMS deemed status, meaning their standards meet or exceed CLIA and their inspection substitutes for a CMS survey. CAP uses a two-year cycle with a self-inspection in the alternate year and unannounced on-site inspections. Standards such as CLSI guidelines are consensus documents, not regulations, but accreditors frequently incorporate them by reference.

2. Proficiency Testing

Proficiency testing is external quality assessment: an approved provider sends unknown specimens, the laboratory analyzes them and reports results, and the provider grades them against peer or definitive values.

The Operating Rules

  • Rule Requirement
  • Enrollment Required for each regulated analyte performed, with an approved provider
  • Frequency Three testing events per year, generally five challenges per analyte per event

Handling Samples must be integrated into the routine workflow , tested by personnel who routinely perform the assay, using the laboratory's routine methods

No duplicate testing Samples may not be analyzed in replicate unless patient specimens are routinely run in replicate

No referral Sending a proficiency testing sample to another laboratory is the most serious violation and can trigger revocation of the CLIA certificate

No communication Discussing results with another laboratory before the reporting deadline is prohibited

Passing score 80 percent of challenges correct for each analyte per event; ABO grouping, Rh typing, and compatibility testing require 100 percent

Unsuccessful performance Two consecutive or two of three consecutive unsuccessful events trigger sanctions, including loss of the right to test that analyte

Documentation Attestation, results, evaluation, and corrective action retained for two years

Alternative performance assessment is required at least twice per year for analytes with no approved proficiency testing program. Acceptable approaches include split-sample exchange with another laboratory, split samples with a reference method, blinded internal replicates, and clinical correlation with an independent method.

3. Competency Assessment

Competency assessment applies to every person who performs nonwaived testing. It is separate from initial training and from continuing education.

Timing

Competency is assessed at the end of the first six months and again at the end of the first twelve months for new testing personnel, and annually thereafter. Reassessment is also required whenever job responsibilities change or performance problems arise.

The Six Required Elements

Direct observation of routine patient test performance, including specimen handling, processing, and testing.

Monitoring the recording and reporting of test results.

Review of intermediate results, quality control records, proficiency testing results, and preventive maintenance records.

Direct observation of instrument maintenance and function checks.

Assessment of test performance using previously analyzed specimens, internal blind specimens, or external proficiency testing samples.

Assessment of problem-solving skills.

All six elements must be documented for each test system, not merely for the department, and the assessor must be qualified at or above the level of the person being assessed. Continuing education, competency assessment, and annual safety training are three distinct obligations and cannot substitute for one another.